Diabetes incidence before and after COVID-19 vaccination - Results from the German Disease Analyzer database
- PMID: 37448976
- PMCID: PMC10290168
- DOI: 10.1016/j.jvacx.2023.100336
Diabetes incidence before and after COVID-19 vaccination - Results from the German Disease Analyzer database
Abstract
Objective: We investigated whether COVID-19 vaccination had an impact on diabetes risk.
Methods: We used data of 6,198 patients (mean age 64.3 years) from the nationwide Disease Analyzer database, a representative panel of physicians' practices in Germany. Patients received their first COVID-19 vaccination between 1 April 2021 and 31 March 2022, and all were newly diagnosed with diabetes within 183 days before or after this vaccination. Incident rates of diabetes after vaccination were compared to incident rates before vaccination.
Results: The incidence rate of diabetes was lower after vaccination than before vaccination (incidence rate ratio = 0.79, 95% confidence interval: 0.75-0.83). The number of incident cases of diabetes was not greater in 2021 than in 2019.
Conclusion: Our study did not confirm an increased risk of diabetes after COVID-19 vaccination. Further studies are needed to show whether the vaccination may be associated with a reduced diabetes risk.
Keywords: COVID-19; Diabetes mellitus; SARS-CoV-2; Vaccination.
© 2023 The Author(s).
Conflict of interest statement
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures
Similar articles
-
Routine care for people with newly diagnosed type 2 diabetes before and during the SARS-CoV-2 pandemic - results from the German Disease Analyzer database.Prim Care Diabetes. 2023 Aug;17(4):321-326. doi: 10.1016/j.pcd.2023.05.009. Epub 2023 Jun 1. Prim Care Diabetes. 2023. PMID: 37302936 Free PMC article.
-
Incidence of newly diagnosed diabetes after Covid-19.Diabetologia. 2022 Jun;65(6):949-954. doi: 10.1007/s00125-022-05670-0. Epub 2022 Mar 16. Diabetologia. 2022. PMID: 35292829 Free PMC article.
-
Effects of the COVID-19 pandemic on clinically diagnosed psychiatric disorders in persons with type 2 diabetes.Diabet Med. 2022 Aug;39(8):e14852. doi: 10.1111/dme.14852. Epub 2022 Apr 20. Diabet Med. 2022. PMID: 35426166 Free PMC article.
-
No increased incidence of venous thrombosis or pulmonary embolism after SARS-CoV-2 vaccination in Germany.Public Health. 2022 Jun;207:14-18. doi: 10.1016/j.puhe.2022.03.004. Epub 2022 Mar 16. Public Health. 2022. PMID: 35461122 Free PMC article.
-
A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.Trials. 2021 Apr 13;22(1):276. doi: 10.1186/s13063-021-05180-1. Trials. 2021. PMID: 33849629 Free PMC article.
Cited by
-
Comment on Hsieh et al. COVID-19 Vaccination Prior to SARS-CoV-2 Infection Reduced Risk of Subsequent Diabetes Mellitus: A Real-World Investigation Using U.S. Electronic Health Records. Diabetes Care 2023;46:2193-2200.Diabetes Care. 2024 Nov 1;47(11):e92-e93. doi: 10.2337/dc23-2455. Diabetes Care. 2024. PMID: 39432772 Free PMC article. No abstract available.
References
-
- Aberer F., Moser O., Aziz F., Sourij C., Ziko H., Lenz J., et al. Impact of COVID-19 vaccination on glycemia in individuals with type 1 and type 2 diabetes: substudy of the COVAC-DM Study. Diabetes Care. 2022;45(2):e24–e26. - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous